Healthcare Providers and Services

BSX AXNX: Boston Scientific Announces Pricing of €2 Billion Notes Offering

Boston Scientific Corp (BSX stock) announces €2 billion notes offering, financing strategic AXNX acquisition and providing investment opportunities.

Merck to Strengthen Cancer Drug Portfolio with Harpoon Buy

Merck's bold move to acquire Harpoon Therapeutics signals a significant shift in cancer treatment. Learn how this impacts the oncology sector.

Eli Lilly's Zepbound Shows Short-Lived Weight Loss Benefits

Uncover key investment insights in the dynamic obesity drug market. Discover growth, value, and momentum strategies in this evolving healthcare sector.

Beauty Health (SKIN Stock) Faces Market Turbulence, CEO Departs

Beauty Health's stock drops 64%, showing the market's reaction to its financial and operational struggles and highlighting risks and opportunities for investors.

FDA Approves Eli Lilly's Weight Loss Drug Zepbound

Eli Lilly's Tirzepatide drug, already approved for treating Type 2 diabetes as Mounjaro, has received FDA approval for weight management under the name Zepbound.

Daily Stock Watch: Intuitive Surgical Climbs on Q3 Earnings Beat

Intuitive Surgical (NASDAQ: ISRG) has exceeded expectations with its latest earnings update, sending its share price higher. But is ISRG stock a good investment?

Daily Stock Watch: CANO Stock Sinks on Sale Uncertainty

With the share price of Cano Health (NYSE: CANO) dropping sharply after a major player backed out of discussions to purchase the business, we ask if CANO stock is a good investment.

Daily Stock Watch: VRAX Stock Climbs on Monkeypox Testing News

Virax Biolabs Group Ltd (NASDAQ: VRAX) is a heavy gainer on Tuesday morning after its new monkeypox rapid antigen test kits grabbed investors' attention. But is VRAX stock worth investigating?

Daily Stock Watch: Figs (NYSE: FIGS) Stock Slips

After a short-lived rally, the Figs (NYSE: FIGS) stock price dips. Is FIGS stock a good long-term investment?

Daily Stock Watch: Is Signify Health Stock a Buy?

Investors are snapping up shares of Signify Health (NYSE: SGFY) amid reports that the healthcare business is attracting acquisition bids from Amazon, UnitedHealth and CVS.

Daily Stock Watch: Is Invitae Stock Worth Buying?

Today we examine Invitae Corporation (NYSE: NVTA) stock, which has seen its price stumble on Tuesday morning. Is this testing specialist a good investment?

Is Pfizer Stock a Buy as COVID Pills Gear Up for Approval?

Pfizer's COVID-19 pill, vaccine and CFO resignation are making headlines this week. Does the news help boost its investment thesis?

Investing in a Post-COVID Healthcare Revolution

The healthcare industry is vast, covering an array of disciplines, ideas and revolutionary changes. Read on to discover how investing in this domain can be lucrative.